Research Site — Shandong

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

250

Registered studies

160

Active

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Breast Neoplasms · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Squamous Cell Carcinoma of Head and Neck

Recently updated registry entries

NCT06136559 — A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib… (Recruiting)
NCT06890598 — Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With… (Recruiting)
NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.